Healthcare

Micro-X develops X-ray products built around a proprietary cold-cathode emitter technology that uses carbon nanotubes to generate X-rays. Conventional X-ray tubes rely on heating a filament, which requires bulky, power-hungry hardware. Micro-X’s cold-cathode approach switches X-rays on and off electronically, allowing dramatically smaller, lighter …

OncoSil is a medical-device company built around a single targeted-radiation product. The OncoSil device is a Class III implant that delivers Phosphorus-32 (a radioactive isotope) as microparticles injected directly into a pancreatic tumour, a form of internal, targeted radiation known as brachytherapy. It is …

• Nexsen is developing rapid point-of-care diagnostic technologies, with StrepSure Group B Streptococcus testing as its lead commercial program.

• Compumedics is a medical-technology company developing diagnostic solutions across sleep medicine, neurology, brain imaging and blood-flow monitoring.

For a company operating in the clinical-stage biotechnology segment, funding announcements of this nature are often closely watched by the market given the ongoing capital requirements associated with running clinical trials. The share price reaction on the day suggests the market viewed the facility …

In her place, Adherium's Chief Commercial Officer, John Perry, has been appointed Interim Chief Executive Officer with immediate effect. The company said the appointment is intended to provide leadership continuity as it continues to advance its Remote Patient Monitoring and Value Based Care growth …

Cleo Diagnostics Limited (ASX:COV), a Melbourne-based diagnostic company specialising in ovarian cancer detection, has reached a significant regulatory milestone as it progresses toward commercialisation in the United States. The company's quarterly activities report, released on 29 July 2026, outlines advancement into the analytical validation …